Advisory Council on the Misuse of Drugs. (2008) GBL & 1,4-BD: Assessment of risk to the individual and communities in the UK. London: Home Office.
Preview | Title | Contact |
---|---|---|
|
PDF (Gamma-butyrolactone (GBL) report)
- Published Version
240kB |
Gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) are precursor chemicals that are rapidly converted (half-life approximately 1min) to the intoxicant gamma-hydroxybutyrate (GHB) when ingested into the human body.
GHB occurs naturally in small amounts in the brain, and is recognised by specific receptors. It may be an inhibitory neuromodulator, involved among other things in the control of glucose metabolism, oxygen consumption and temperature regulation.
B Substances > Sedatives, hypnotics or tranquillisers (CNS depressants)
B Substances > New (novel) psychoactive substances > GHB (Gamma hydroxybutyric acid)
J Health care, prevention, harm reduction and rehabilitation > Risk and needs assessment > Risk assessment
J Health care, prevention, harm reduction and rehabilitation > Health care administration > Health care quality control
L Social psychology and related concepts > Legal availability or accessibility
VA Geographic area > Europe > United Kingdom
Repository Staff Only: item control page